ATE302001T1 - Stabilisierte askorbinsäurederivate - Google Patents

Stabilisierte askorbinsäurederivate

Info

Publication number: ATE302001T1
Authority: AT; Austria
Prior art keywords: ascorbic acid; acid derivatives; stabilized ascorbic; carbon atoms; stabilized
Prior art date: 2002-04-12

Application number

AT03717570T

Other languages

English (en)

Inventor

Norihito Nishimura

Kawasaki-Ku Cho

Hiroshi Ishii

Makoto Saito

Original Assignee

Showa Denko Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-12

Filing date

2003-04-11

Publication date

2005-09-15

2003-04-11 Application filed by Showa Denko Kk filed Critical Showa Denko Kk

2005-09-15 Application granted granted Critical

2005-09-15 Publication of ATE302001T1 publication Critical patent/ATE302001T1/de

Links

150000000996 L-ascorbic acids Chemical class 0.000 title 1
125000004432 carbon atom Chemical group C* 0.000 abstract 2
125000000217 alkyl group Chemical group 0.000 abstract 1
125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000006239 protecting group Chemical group 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
- C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Organic Chemistry (AREA)
Dermatology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Gerontology & Geriatric Medicine (AREA)
Birds (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Toxicology (AREA)
Nutrition Science (AREA)
Cosmetics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Furan Compounds (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Anti-Oxidant Or Stabilizer Compositions (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

AT03717570T 2002-04-12 2003-04-11 Stabilisierte askorbinsäurederivate ATE302001T1 (de)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2002110341		2002-04-12
US37360902P	2002-04-19	2002-04-19
PCT/JP2003/004659 WO2003086384A1 (en)	2002-04-12	2003-04-11	Stabilized ascorbic acid derivatives

Publications (1)

Publication Number	Publication Date
ATE302001T1 true ATE302001T1 (de)	2005-09-15

Family

ID=29253536

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT03717570T ATE302001T1 (de)	2002-04-12	2003-04-11	Stabilisierte askorbinsäurederivate

Country Status (10)

Country	Link
US (2)	US7223775B2 (de)
EP (1)	EP1496889B1 (de)
JP (1)	JP4111856B2 (de)
CN (1)	CN1297266C (de)
AT (1)	ATE302001T1 (de)
AU (1)	AU2003222450A1 (de)
CA (1)	CA2481591C (de)
DE (1)	DE60301345T2 (de)
ES (1)	ES2243901T3 (de)
WO (1)	WO2003086384A1 (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8278350B2 (en)	2003-10-14	2012-10-02	Showa Denko K.K.	Agent for skin external use containing salt of ascorbic acid derivative, method for stabilizing the agent for skin external use, and stabilizer
JP4190539B2 (ja) *	2004-03-25	2008-12-03	東洋ビューティ株式会社	アスコルビン酸誘導体および美白化粧料
TW200534875A (en) *	2004-04-23	2005-11-01	Lonza Ag	Personal care compositions and concentrates for making the same
WO2005102267A1 (en) *	2004-04-26	2005-11-03	Showa Denko K.K.	Agent for skin external use containing tocopherol derivative, ascorbic acid derivative and surface active agent having lipopeptide structure
JP4786419B2 (ja) *	2006-05-30	2011-10-05	日本メナード化粧品株式会社	アスコルビン酸−２−リン酸エステル誘導体を含有する組成物
JP5342102B2 (ja) *	2006-07-04	2013-11-13	昭和電工株式会社	エマルション組成物
DE102006037724A1 (de) *	2006-08-11	2008-02-14	Merck Patent Gmbh	Verwendung von Ascorbinsäurederivaten zur Funktionalisierung von Matrices
US20130115320A1 (en)	2007-03-30	2013-05-09	Dynova Laboratories, Inc.	Therapeutic agent for intranasal administration and method of making and using same
US8211477B2 (en) *	2007-10-17	2012-07-03	Biova, L.L.C.	Solubilized protein composition obtained from eggshell membrane
US7749284B2 (en) *	2008-04-28	2010-07-06	Aveda Corporation	Oxidative hair dye compositions, methods and products
MX2011001071A (es) *	2008-08-06	2011-04-26	Daiichi Sankyo Healthcare Co	Composicion farmaceutica estable que contiene acido tranexamico y acido ascorbico.
GB2470040A (en) *	2009-05-06	2010-11-10	Systagenix Wound Man Ip Co Bv	Wound dressing material comprising N-acetyl cysteine
JP5552386B2 (ja) *	2010-07-09	2014-07-16	株式会社ファンケル	Ｌ−アスコルビン酸−２−リン酸−６−脂肪酸凍結乾燥製剤及び化粧料
US8435541B2 (en)	2010-09-02	2013-05-07	Bath & Body Works Brand Management, Inc.	Topical compositions for inhibiting matrix metalloproteases and providing antioxidative activities
US20130022687A1 (en) *	2011-07-19	2013-01-24	Fitzgerald Jr John James	Topical transdermal method for delivering nutrients through the skin for expedited wound healing
FR2978963A1 (fr)	2011-08-11	2013-02-15	Ascorbix	Nouveaux derives des furanones et composition pharmaceutique les contenant
EP3988537A1 (de)	2011-12-07	2022-04-27	Alnylam Pharmaceuticals, Inc.	Biologisch abbaubare lipide zur freisetzung von wirkstoffen
JP6001902B2 (ja) *	2012-03-30	2016-10-05	株式会社コーセー	アスコルビン酸誘導体が配合された組成物
JP6010317B2 (ja) *	2012-03-30	2016-10-19	株式会社コーセー	アスコルビン酸誘導体が配合された水中油型乳化組成物
CN104135997B (zh) *	2012-12-20	2017-03-22	昭和电工株式会社	抗坏血酸衍生物组合物及其制造方法、抗坏血酸衍生物溶液、皮肤外用剂
JP6173440B2 (ja) *	2013-04-23	2017-08-02	株式会社ニチレイバイオサイエンス	新規美白剤
TW201513853A (zh) *	2013-07-25	2015-04-16	Cheryl Lee Eberting	用於表皮修復和皮膚疾患治療的配方
CN103445018B (zh) *	2013-08-22	2014-11-12	福建天马科技集团股份有限公司	虹鳟稚鱼浮性膨化颗粒配合饲料
CN103554070A (zh) *	2013-11-08	2014-02-05	李玉成	抗坏血酸氧铋、其制备方法及应用
IL289934B2 (en)	2014-06-25	2023-04-01	Acuitas Therapeutics Inc	Novel lipids and lipid nanoparticle formulations for delivery of nucleic acids
EP3289083A4 (de)	2015-04-27	2018-12-19	The Trustees Of The University Of Pennsylvania	Nukleosidmodifizierte rna zur induktion einer adaptiven immunantwort
CN114085198A (zh)	2015-06-29	2022-02-25	爱康泰生治疗公司	用于递送核酸的脂质和脂质纳米颗粒制剂
RS63986B1 (sr)	2015-10-28	2023-03-31	Acuitas Therapeutics Inc	Novi lipidi i lipidne formulacije nanočestica za isporuku nukleinskih kiselina
US12491261B2 (en)	2016-10-26	2025-12-09	Acuitas Therapeutics, Inc.	Lipid nanoparticle formulations
US11241490B2 (en)	2017-01-11	2022-02-08	The Trustees Of The University Of Pennsylvania	Nucleoside-modified RNA for inducing an immune response against zika virus
WO2018191657A1 (en)	2017-04-13	2018-10-18	Acuitas Therapeutics, Inc.	Lipids for delivery of active agents
WO2018200943A1 (en)	2017-04-28	2018-11-01	Acuitas Therapeutics, Inc.	Novel carbonyl lipids and lipid nanoparticle formulations for delivery of nucleic acids
WO2019036008A1 (en)	2017-08-16	2019-02-21	Acuitas Therapeutics, Inc.	LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
WO2019036030A1 (en)	2017-08-17	2019-02-21	Acuitas Therapeutics, Inc.	LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS
WO2019036028A1 (en)	2017-08-17	2019-02-21	Acuitas Therapeutics, Inc.	LIPIDS FOR USE IN LIPID NANOPARTICULAR FORMULATIONS
JP7461872B2 (ja)	2017-08-17	2024-04-04	アクイタスセラピューティクスインコーポレイテッド	脂質ナノ粒子製剤における使用のための脂質
US11273422B2 (en) *	2018-06-07	2022-03-15	Powdermet, Inc.	Non-linear surfactant
EP4613367A1 (de)	2018-09-21	2025-09-10	Acuitas Therapeutics, Inc.	Systeme und verfahren zur herstellung von lipidnanopartikeln und liposomen
CA3125485A1 (en)	2019-01-11	2020-07-16	Acuitas Therapeutics, Inc.	Lipids for lipid nanoparticle delivery of active agents
DK4182297T3 (da)	2020-07-16	2025-12-01	Acuitas Therapeutics Inc	Kationiske lipider til brug i lipid-nanopartikler
WO2022059763A1 (ja) *	2020-09-17	2022-03-24	昭和電工株式会社	オートファジー活性化剤
JP7276887B2 (ja) *	2020-11-30	2023-05-18	東洋ビューティ株式会社	Ｉｉｉ型コラーゲン産生促進剤および抗老化化粧料
CN117642415A (zh)	2021-05-20	2024-03-01	罗可欧普科有限公司	含有维生素c化合物的化妆品组合物及其用途
WO2023114943A2 (en)	2021-12-16	2023-06-22	Acuitas Therapeutics, Inc.	Lipids for use in lipid nanoparticle formulations
CN115154349A (zh) *	2022-07-19	2022-10-11	何直源	一种基于硫代二丙酸和抗坏血酸的美白组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5218191B1 (de)	1967-10-31	1977-05-20
JPS58222078A (ja) *	1982-06-17	1983-12-23	Santen Pharmaceut Co Ltd	アスコルビン酸誘導体
JPS58222076A (ja)	1982-06-17	1983-12-23	Toyama Chem Co Ltd	２−アミノチアゾ−ル誘導体
JPS6150908A (ja) *	1984-08-20	1986-03-13	Kanebo Ltd	皮膚化粧料
JPS61152613A (ja) *	1984-12-26	1986-07-11	Kanebo Ltd	皮膚化粧料
IL89850A0 (en) *	1988-04-25	1989-12-15	Takeda Chemical Industries Ltd	Ester of ascorbic acid 2-phosphate
EP0875246A1 (de)	1997-04-04	1998-11-04	Showa Denko Kabushiki Kaisha	Pharmazeutische Zusammensetzung aus Ascorbinsäurederivate zur Behandlung von Krebs
FR2762607B1 (fr)	1997-04-29	1999-06-11	Atochem Elf Sa	Systeme monocomposant a base de latex coreactifs conduisant a des revetements reticulables a temperature ambiante et post-reticulables par traitement et leur application dans le domaine des revetements
JPH10298174A (ja) *	1997-04-30	1998-11-10	Showa Denko Kk	アスコルビン酸誘導体及びそれを含有するビタミンｃ剤
DE19936686A1 (de) *	1999-08-04	2001-02-08	Beiersdorf Ag	Verwendung von kosmetischen oder dermatologischen Zubereitungen zur Stabilisierung von Ascorbinsäure und/oder Ascorbylverbindungen
WO2001064245A1 (fr) *	2000-02-29	2001-09-07	Showa Denko K.K.	Composition de renforcement immunitaire et utilisation de ces compositions

2003
- 2003-03-31 JP JP2003096750A patent/JP4111856B2/ja not_active Expired - Lifetime
- 2003-04-11 CA CA002481591A patent/CA2481591C/en not_active Expired - Fee Related
- 2003-04-11 AU AU2003222450A patent/AU2003222450A1/en not_active Abandoned
- 2003-04-11 ES ES03717570T patent/ES2243901T3/es not_active Expired - Lifetime
- 2003-04-11 US US10/510,756 patent/US7223775B2/en not_active Expired - Fee Related
- 2003-04-11 CN CNB038134462A patent/CN1297266C/zh not_active Expired - Fee Related
- 2003-04-11 WO PCT/JP2003/004659 patent/WO2003086384A1/en not_active Ceased
- 2003-04-11 AT AT03717570T patent/ATE302001T1/de not_active IP Right Cessation
- 2003-04-11 EP EP03717570A patent/EP1496889B1/de not_active Expired - Lifetime
- 2003-04-11 DE DE60301345T patent/DE60301345T2/de not_active Expired - Lifetime
2007
- 2007-02-08 US US11/672,677 patent/US7507750B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
DE60301345T2 (de)	2006-06-29
EP1496889A1 (de)	2005-01-19
US20070141000A1 (en)	2007-06-21
US7223775B2 (en)	2007-05-29
JP4111856B2 (ja)	2008-07-02
US20060100177A1 (en)	2006-05-11
CA2481591C (en)	2009-08-18
CA2481591A1 (en)	2003-10-23
US7507750B2 (en)	2009-03-24
DE60301345D1 (de)	2005-09-22
JP2004002359A (ja)	2004-01-08
CN1658864A (zh)	2005-08-24
ES2243901T3 (es)	2005-12-01
WO2003086384A1 (en)	2003-10-23
EP1496889B1 (de)	2005-08-17
AU2003222450A1 (en)	2003-10-27
CN1297266C (zh)	2007-01-31

Legal Events

Date	Code	Title	Description
2006-02-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
DE60301345D1 (de)	2005-09-22	Stabilisierte askorbinsäurederivate
MX2010013275A (es)	2011-03-15	Compuesto novedoso de uracilo o su sal que tiene actividad inhibidora de desoxiuridin trifosfatasa de humano.
WO2008114819A1 (ja)	2008-09-25	新規アデニン化合物
TW200606137A (en)	2006-02-16	Urea derivatives
TWI265929B (en)	2006-11-11	Triazinyl derivatives for inhibiting the production of IL-12
EP1634874A4 (de)	2008-04-02	Imidazolidinderivate
ATE125539T1 (de)	1995-08-15	1,4-benzothiazedinderivat.
MX2010001344A (es)	2010-03-01	Compuesto de acido fenilacetico.
EA200200098A1 (ru)	2002-10-31	Ароматические сложные эфиры для маркировки или мечения нефтепродуктов
UA89672C2 (en)	2010-02-25	Sulfonylamino(thio)carbonyl compounds
WO2004080408A3 (en)	2004-12-09	Method of treating cancer with azaspirane compositions
BRPI0411664A (pt)	2006-08-08	composição oral antiplaca aquosa estável
ES2188481T3 (es)	2003-07-01	Derivados de polinalbufina.
WO2008090717A1 (ja)	2008-07-31	Ａｄａｍ阻害剤
WO2008102546A1 (ja)	2008-08-28	チエタン化合物、これを含む重合性組成物およびその使用
DE69930383D1 (de)	2006-05-11	Naphthimidobenzamid-derivate
DK0601191T3 (da)	1999-04-26	Hidtil ukendt tetracyklisk forbindelse
AU2003226456A1 (en)	2003-10-27	Ptx3 gene expression suppressing method
EP1403250A4 (de)	2005-04-13	Bis(5-aryl-2-pyridyl)derivate
EA200500716A1 (ru)	2005-10-27	Новые соединения 2,3-дигидро-4-(1h)-пиридона, способ их получения и фармацевтические композиции, которые их содержат
TW200504057A (en)	2005-02-01	Benzothiophene derivative
EP1484319A4 (de)	2007-01-24	Kettenförmiger oligomilchsäurethioester
WO2003033494A1 (en)	2003-04-24	Benzimidazole derivative
MXPA05008190A (es)	2006-02-17	Derivado de oligosacarido.
GB0412893D0 (en)	2004-07-14	Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles